Tiziana Life Sciences (TLSA) announces that its Executive Chairman and Founder, Gabriele Cerrone, has purchased 97,687 common shares, bringing his total holding to 43,374,830 common shares, which is 36.08% of issued share capital.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSA:
- Tiziana Life Sciences Rings Nasdaq Closing Bell Celebrating Milestone in Biotechnology
- Tiziana Life Sciences Doses First Patient in Critical Phase 2 Alzheimer’s Trial
- Tiziana Life Sciences doses first patient in Phase 2 Alzheimer’s trial
- Tiziana Life Sciences CEO Increases Stake with Significant Share Purchase
- Tiziana Life Sciences CEO Ivor Elrifi purchases 163,400 shares